Thursday, May 6, 2021

Natco rolls out Baricitinib ahead of approval for patent waiver

Even as it has filed for a compulsory licence for Covid-19 drug Baricitinib in India, Natco Pharma has already begun rolling out its generic version of the rheumatoid arthritis drug under the Barinat brand.

from Business News: Latest News on Business, Stock Markets, Financial News, India Business & World Business News https://ift.tt/3trt98X
at
Labels: , , ,

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)

Viral Video Shows 3,000 Engineers Queuing Up For Job Interview In Pune

In a viral video, over 3,000 engineers were seen queuing outside a Pune-based company for a recent walk-in drive targeting junior developer ...